MELINDA GATES STEPS DOWN FROM DRUGSTORE.COM
Melinda Gates announced late August 21, 2006 that she is stepping down from the board of Bellevue, Washington-based Drugstore.com Inc., an online seller of health, vision and pharmaceutical products. Melinda resigned in order to spend more time running the Bill & Melinda Gates Foundation, where she serves as co-chair with husband and Microsoft founder Bill Gates. Melinda had been on the board since 1999. (UPI Photo/Ezio Petersen/FILE)
UPI Related News
IRVINE, Calif., Sept. 18 (UPI) -- One of the world's richest couples, Bill and Melinda Gates, have donated $1.7 million to the University of California for a study of the world's poorest people.
NEW YORK, July 25 (UPI) -- New York Mayor Michael Bloomberg and Microsoft founder Bill Gates said they will invest $500 million to help governments in developing countries combat tobacco.
REDMOND, Wash., June 27 (UPI) -- Friday is the last day at work at Microsoft for Bill Gates, one of the must iconic success stories in the history of the U.S. business world.
UPI Almanac for Wednesday, June 25, 2008.
BIRMINGHAM, Ala., April 14 (UPI) -- U.S. scientists are questioning how millions of dollars dedicated to malaria prevention are being spent since annual deaths from the disease are increasing.
SEATTLE, Jan. 25 (UPI) -- The Bill & Melinda Gates Foundation says it is expanding its charity work in agricultural development with $306 million earmarked for six farming programs.
SEATTLE, Jan. 20 (UPI) -- The Bill & Melinda Gates Foundation in Seattle is attempting to help poor farmers around the world by offering agricultural assistance.
WASHINGTON, Dec. 26 (UPI) -- Efforts to wipe out polio have stalled in recent years and eradication of the crippling disease remains a question mark, U.S. and world experts say.
NEW YORK, Dec. 12 (UPI) -- The Weill Cornell Medical College in New York has received grants totaling $2.4 million from the Bill & Melinda Gates Foundation for tuberculosis research.
WASHINGTON, Nov. 20 (UPI) -- A U.S. Senate panel is examining claims a top official at the Gates Foundation tried to cover up a diabetes drug's potential side effects in his previous job.